Viridos Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 52

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $25M

  • Investors
  • 19

Viridos General Information

Description

Developer of a genomic-driven technology designed to address global energy and environmental challenges. The company's technology focuses on bio-based production targeted at improving existing biological production hosts and developing entirely new synthetic production hosts, enabling academic and commercial research and development organizations to efficiently produce pharmaceuticals, vaccines, and nutritional and bio-industrial products derived from renewable biological resources.

Contact Information

Website
www.viridos.com
Formerly Known As
Synthetic Genomic Solutions, Synthetic Genomics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 11149 North Torrey Pines Road
  • La Jolla, CA 92037
  • United States
+1 (858)
Primary Industry
Other Agriculture
Other Industries
Environmental Services (B2B)
Corporate Office
  • 11149 North Torrey Pines Road
  • La Jolla, CA 92037
  • United States
+1 (858)

Viridos Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Viridos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series A) 13-Mar-2023 $25M Completed Generating Revenue
9. Grant 26-Jan-2023 Completed Generating Revenue
8. Later Stage VC (Series E1) 22-Sep-2015 Completed Generating Revenue
7. Later Stage VC (Series E) 06-May-2014 Completed Generating Revenue
6. Later Stage VC (Series D) 05-Feb-2013 Completed Generating Revenue
5. Grant 01-Jan-2013 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2012 Completed Generating Revenue
3. Later Stage VC (Series C) 31-Dec-2010 Completed Generating Revenue
2. Early Stage VC (Series B) 31-May-2007 $70M $110M Completed Startup
1. Early Stage VC (Series A) 11-Oct-2005 $40M $40M Completed Startup
To view Viridos’s complete valuation and funding history, request access »

Viridos Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E1
Series E
Series D
Series C
Series B 13,793,094 $0.002000 8% $5.08 $5.08 $5.08 13.84%
Series A 7,696,653 $0.002000 8% $4 $4 1x $4 7.72%
To view Viridos’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Viridos Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a genomic-driven technology designed to address global energy and environmental challenges. The company's t
Other Agriculture
La Jolla, CA
52 As of 2025

Gilbert, AZ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Viridos Competitors (1)

One of Viridos’s competitors is PhycoTerra, a Corporate Backed or Acquired company based in Gilbert, AZ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PhycoTerra Corporate Backed or Acquired Gilbert, AZ
You’re viewing 1 of 1 competitors. Get the full list »

Viridos Patents

Viridos Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026024652-A1 Recombinant algae having high biomass and lipid productivity Pending 22-Jul-2024
WO-2025064430-A1 Recombinant algae having high biomass and lipid productivity Inactive 18-Sep-2023
WO-2025034558-A1 Method for nuclear genome editing using plastid selectable markers Inactive 04-Aug-2023
WO-2024097353-A1 Recombinant algae having high biomass and lipid productivity Inactive 04-Nov-2022
US-12618078-B2 Chlorophyte algae having improved productivity Active 23-Apr-2021 C12N9/22
To view Viridos’s complete patent history, request access »

Viridos Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Viridos Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds
Breakthrough Energy Impact Investing Minority
Chevron Corporation Minority
Draper Associates Venture Capital Minority
United Airlines Holdings Holding Company Minority
U.S. Department of Energy Government
You’re viewing 5 of 19 investors. Get the full list »

Viridos Investments (2)

Viridos’s most recent deal was a Joint Venture with Algae Biofuel Research Program (ExxonMobil / Synthetic Genomics). The deal was made on 06-Mar-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Algae Biofuel Research Program (ExxonMobil / Synthetic Genomics) 06-Mar-2018 Joint Venture Other Energy Services
Agradis 24-Oct-2011 Early Stage VC Agricultural Chemicals
To view Viridos’s complete investments history, request access »

Viridos FAQs

  • When was Viridos founded?

    Viridos was founded in 2005.

  • Where is Viridos headquartered?

    Viridos is headquartered in La Jolla, CA.

  • What is the size of Viridos?

    Viridos has 52 total employees.

  • What industry is Viridos in?

    Viridos’s primary industry is Other Agriculture.

  • Is Viridos a private or public company?

    Viridos is a Private company.

  • What is Viridos’s current revenue?

    The current revenue for Viridos is .

  • How much funding has Viridos raised over time?

    Viridos has raised $330M.

  • Who are Viridos’s investors?

    Breakthrough Energy, Chevron, Draper Associates, United Airlines Holdings, and U.S. Department of Energy are 5 of 19 investors who have invested in Viridos.

  • Who are Viridos’s competitors?

    PhycoTerra is a competitor of Viridos.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process